Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Healthcare
Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Quantum BioPharma Ltd > PENG23 & dayanpantig01...Remember These Posts
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(3)
•••
Comment by Mil_Man54on Jan 29, 2021 5:53pm
30 Views
Post# 32426265

RE:RE:RE:PENG23 & dayanpantig01...Remember These Posts

RE:RE:RE:PENG23 & dayanpantig01...Remember These PostsYou're just a pathetic pumper who has been told to start bashing the Raza by your boss at Forst Republic.....IMO

Mil_Man54 wrote: Well let's try again then and refresh your memory....

October 27, 2020 - 09:33 AM
19 Reads
Post# 31787414

WITH THE TEAM'S EFFORT

With a highly-accomplished Board of Directors and BioSciences team, they have the adequate dept and breadth required to pursue their strategic vision.

October 27, 2020 - 09:33 AM
15 Reads
Post# 31787419

DISCOVERY AND DEVELOPMENT

FDS Pharma comprises of Administration team with various industry knowledge, dedicated to science, therapeutic drug discovery and development.

January 27, 2021 - 08:20 AM
19 Reads
Post# 32397081

FSD Pharma is With the Expertise

With the help of the expertise, the board of directors and BioSciences team, with the adequate wisdom and scope required to pursue their calculated visualization.


January 27, 2021 - 08:20 AM
7 Reads
Post# 32397084

RE:FSD Pharma is With the Expertise

Indeed, Dr. Raza, the CEO of the company has been very responsible for developing and leading FSD’s strategic vision into synthetic cannabinoid platforms.


 






<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities